Development Insights
Kimberly Sullivan possesses extensive experience in regulatory affairs, quality, and compliance within the pharmaceutical industry, currently serving as President and CEO of Development Insights since 2010. Prior to this role, Kimberly served as an independent consultant specializing in quality, compliance, and regulatory affairs. Previous positions include Director of Compliance, Quality, and Regulatory Affairs at Speciality European Pharma and Director of Quality at Praecis Pharmaceuticals. Other notable roles include Principal Manager of Regulatory Affairs/Quality Assurance at Inotek Pharmaceuticals and Manager of Quality Systems/Regulatory Affairs at Collagenesis, Inc. Kimberly’s career began in quality assurance and technical services at Toxikon Corporation and spans back to technical roles in Earth and Marine Sciences at Arthur D. Little.
This person is not in any teams
This person is not in any offices
Development Insights
We understand that the right expertise can provide the essential balance between scientific integrity and progress in development. Whether you are preparing for a regulatory filing, clinical trial initiation, licensing deal, or product approval, we can deliver the solution. Our team has a thorough understanding of historical development challenges, combined with a current knowledge of industry and regulatory trends. We pride ourselves on our innovative thinking and our ability to work with our clients, not just for them.